Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience

PURPOSE: Ablative treatment of oligometastases has shown survival benefit with certain tumors, although these effects still are to be demonstrated in prostate cancer. MATERIALS AND METHODS: We analysed the toxicity and clinical control results obtained in patients with bone-only oligometastatic pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Iglesias, Ángel L., Morillo-Macías, Virginia, Santafé-Jiménez, Ana, Ferrer-Albiach, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535412/
https://www.ncbi.nlm.nih.gov/pubmed/36200308
http://dx.doi.org/10.3857/roj.2022.00101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535412/
https://www.ncbi.nlm.nih.gov/pubmed/36200308
http://dx.doi.org/10.3857/roj.2022.00101

Ejemplares similares